1. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Jalton DAG, Gralnick HR, Sultan C (1976) Proposals for the classification of the acute leukaemias. Br J Haematol 33:451–458
2. Creutzig U, Ritter J, Riehm H, Langermann HJ, Henze G, Kabisch H, Niethammer D, Jürgens H, Stollmann B, Lasson U, Kaufmann U, Löffler H, Schellong G (1985) Improved treatment results in childhood acute myelogenous leukemia: a report of the German cooperative study AML-BFM-78. Blood 65:298–304
3. Creutzig U, Niederbiermann G, Ritter J, Harbott J, Löffler H, Schellong G (1990a) The prognostic significance of eosinophilia in acute myelomonocytic leukemia in relation to induction treatment. In: Büchner Th, Schellong G, Hiddemann W, Ritter J (eds) Hematology and blood transfusion 33. Acute leukemias II. Springer, Berlin Heidelberg New York
4. Creutzig U, Ritter J, Schellong G (1990) Acute myelogenous leukemia in childhood: analysis of therapy studies AML-BFM-78 and -83 as basis for future risk adapted treatment strategies. Monogr, Springer, Berlin Heidelberg New York
5. Henze G, Langermann H-J, Brämswig J et al. (1981) Ergebnisse der Studie BFM 76/79 zur Behandlung der akuten lymphoblastischen Leukämie bei Kindern und Jugendlichen. Klin Pädiatr 193:145–154